Neuroscience R&D newsroom
Thank you for visiting Neuroscience Newsroom!
Below, please find our leadership, our meeting news, social feeds, and more information about our progress and commitment to developing innovative medicines focused on neurodegenerative disorders, such as Alzheimer’s disease and Parkinson’s disease; neuroscience-autoantibody diseases, such as myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; neuropsychiatric disorders, such as major depressive disorder and bipolar disorder.
Below, please find our leadership, our meeting news, social feeds, and more information about our progress and commitment to developing innovative medicines focused on neurodegenerative disorders, such as Alzheimer’s disease and Parkinson’s disease; neuroscience-autoantibody diseases, such as myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; neuropsychiatric disorders, such as major depressive disorder and bipolar disorder.
Our Neuroscience Leadership
Bill Martin, Ph.D.
Global Focus Area Head
Neuroscience
Neuroscience
Peter Fang
Worldwide Vice President
Neuroscience
Global Commercial Strategy Organization
Neuroscience
Global Commercial Strategy Organization
Fiona Elwood, Ph.D.
Vice President
Disease Area Leader
Neurodegeneration
Disease Area Leader
Neurodegeneration
Wayne Drevets, M.D.
Vice President
Disease Area Leader, Neuropsychiatry
Disease Area Leader, Neuropsychiatry
Latest medical meeting news
Related stories